DA Davidson analyst Hans Chung maintains Axcelis Technologies (NASDAQ:ACLS) with a Buy and raises the price target from $105 to $145.
Centessa Pharmaceuticals Q3 EPS $(0.57) Down From $(0.45) YoY
Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.57) per share. This is a 26.67 percent decrease over losses of $(0.45) per share from the same period last year.